NeoMag is the first magneto-mechanical platform that simulates pathological processes in biological systems for more predictive drug testing in a non-invasive, contact-free and portable by design way.
60Nd has raised €2.4M across 1 funding round from 1 investor, most recently a round in Feb 2026. Based in Madrid, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-19 | Other | €2.4M |
| EIC Transition |
| View deal → |
